Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Nephrology in the Academic Intensive Care Unit: A Qualitative Study of Interdisciplinary Collaboration.

Clapp JT, Diraviam SP, Lane-Fall MB, Szymczak JE, Muralidharan M, Chung JJ, Gutsche JT, Curley MAQ, Berns JS, Fleisher LA.

Am J Kidney Dis. 2019 Sep 3. pii: S0272-6386(19)30853-4. doi: 10.1053/j.ajkd.2019.05.030. [Epub ahead of print]

PMID:
31492489
2.

Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease.

Akizawa T, Macdougall IC, Berns JS, Yamamoto H, Taguchi M, Iekushi K, Bernhardt T.

Nephron. 2019 Aug 6:1-12. doi: 10.1159/000502012. [Epub ahead of print]

3.

CPR for OHCA Is Rarely Successful, and What Is "Success" Anyway?

Gelfand SL, Eneanya ND, Leonberg-Yoo AK, Berns JS.

J Am Soc Nephrol. 2019 Jun;30(6):1137. doi: 10.1681/ASN.2019020149. Epub 2019 May 6. No abstract available.

PMID:
31061138
4.

Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.

Akizawa T, Macdougall IC, Berns JS, Bernhardt T, Staedtler G, Taguchi M, Iekushi K, Krueger T.

Am J Nephrol. 2019;49(4):271-280. doi: 10.1159/000499111. Epub 2019 Mar 8. Erratum in: Am J Nephrol. 2019;50(2):160.

5.

Effects of Molidustat in the Treatment of Anemia in CKD.

Macdougall IC, Akizawa T, Berns JS, Bernhardt T, Krueger T.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):28-39. doi: 10.2215/CJN.02510218. Epub 2018 Dec 17. Erratum in: Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1524.

PMID:
30559105
6.

Addressing Financial Disincentives to Improve CKD Care.

Berns JS, Saffer TL, Lin E.

J Am Soc Nephrol. 2018 Nov;29(11):2610-2612. doi: 10.1681/ASN.2018040438. Epub 2018 Oct 10. No abstract available.

PMID:
30305309
7.

Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.

Berns JS, Glickman A, McCoy MS.

N Engl J Med. 2018 Oct 4;379(14):1295-1297. doi: 10.1056/NEJMp1805097. No abstract available.

PMID:
30281994
8.

Kidney Tattoos.

Berns JS.

Am J Kidney Dis. 2019 Jan;73(1):A13-A14. doi: 10.1053/j.ajkd.2018.08.007. Epub 2018 Sep 13. No abstract available.

PMID:
30219592
9.

Training Nephrology Fellows in Temporary Hemodialysis Catheter Placement and Kidney Biopsies is Needed and Should be Required.

Berns JS.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1099-1101. doi: 10.2215/CJN.00040118. Epub 2018 Jun 15. No abstract available.

10.

Accuracy of Acid-Base Diagnoses Using the Central Venous Blood Gas in the Medical Intensive Care Unit.

Schrauben SJ, Negoianu D, Costa C, Cohen RM, Goldfarb S, Fuchs BD, Berns JS.

Nephron. 2018;139(4):293-298. doi: 10.1159/000488501. Epub 2018 Apr 12.

11.

Nutritional Management of Chronic Kidney Disease.

Berns JS.

N Engl J Med. 2018 Feb 8;378(6):584. doi: 10.1056/NEJMc1715765. No abstract available.

PMID:
29419276
12.

Risk of complications with use of aspirin during renal biopsy: A systematic review.

Kumar V, Mitchell MD, Umscheid CA, Berns JS, Hogan JJ.

Clin Nephrol. 2018 Feb;89(2):67-76. doi: 10.5414/CN109274. Review.

PMID:
29319492
13.

Interpretation of the Kidney Disease: Improving Global Outcomes guidelines for iron therapy: commentary and emerging evidence.

Berns JS.

Clin Kidney J. 2017 Dec;10(Suppl 1):i3-i8. doi: 10.1093/ckj/sfx042. Epub 2017 Nov 28. Review.

14.

International Medical Graduates in Nephrology: Roles, Rules, and Future Risks.

Berns JS, Ghosn M, Altamirano RR.

Am J Kidney Dis. 2018 Jul;72(1):113-117. doi: 10.1053/j.ajkd.2017.09.016. Epub 2017 Dec 6. Review.

PMID:
29221624
15.

Transformation of ABIM and What the Changes Mean to Nephrologists.

Ikizler TA, Berns JS.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):164-166. doi: 10.2215/CJN.05700517. Epub 2017 Oct 10. No abstract available.

16.

Dialysis Payment Model Reform: Managing Conflicts Between Profits and Patient Goals of Care Decision Making.

Berns JS, Glickman JD, Reese PP.

Am J Kidney Dis. 2018 Jan;71(1):133-136. doi: 10.1053/j.ajkd.2017.04.024. Epub 2017 Jun 26. No abstract available.

PMID:
28663064
17.

Transforming Nephrology.

Rosner MH, Berns JS.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):331-334. doi: 10.2215/CJN.02310317. Epub 2017 May 4. No abstract available.

18.

Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial.

Sedrak MS, Myers JS, Small DS, Nachamkin I, Ziemba JB, Murray D, Kurtzman GW, Zhu J, Wang W, Mincarelli D, Danoski D, Wells BP, Berns JS, Brennan PJ, Hanson CW, Dine CJ, Patel MS.

JAMA Intern Med. 2017 Jul 1;177(7):939-945. doi: 10.1001/jamainternmed.2017.1144.

19.

More May be Less; Yet Another Way which More Intense Renal Replacement Therapy May Not be Better.

Besharatian BD, Berns JS.

Semin Dial. 2016 Nov;29(6):515-517. doi: 10.1111/sdi.12556. Epub 2016 Oct 10. No abstract available.

PMID:
27726171
20.

Honoring Patient Preferences: The 2016 National Kidney Foundation Presidential Address.

Berns JS.

Am J Kidney Dis. 2016 Nov;68(5):661-664. doi: 10.1053/j.ajkd.2016.07.018. Epub 2016 Aug 21. No abstract available.

PMID:
27555104
21.

Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report.

Kramer H, Yee J, Weiner DE, Bansal V, Choi MJ, Brereton L, Berns JS, Samaniego-Picota M, Scheel P Jr, Rocco M.

Am J Kidney Dis. 2016 Oct;68(4):522-532. doi: 10.1053/j.ajkd.2016.06.010. Epub 2016 Jul 19.

PMID:
27449697
22.

Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.

Liu Y, Weisberg LS, Langman CB, Logan A, Hunter K, Prasad D, Avila J, Venkatchalam T, Berns JS, Handelman GJ, Sirover WD.

Clin Biochem. 2016 Oct;49(15):1133-1139. doi: 10.1016/j.clinbiochem.2016.05.025. Epub 2016 Jun 3.

PMID:
27265723
23.

Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.

Bahrainwala J, Berns JS.

Semin Nephrol. 2016 Mar;36(2):94-8. doi: 10.1016/j.semnephrol.2016.02.002. Review.

PMID:
27236129
24.

Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee.

Uhlig K, Berns JS, Carville S, Chan W, Cheung M, Guyatt GH, Hart A, Lewis SZ, Tonelli M, Webster AC, Wilt TJ, Kasiske BL.

Kidney Int. 2016 Apr;89(4):753-60. doi: 10.1016/j.kint.2015.11.030.

25.

The Native Kidney Biopsy: Update and Evidence for Best Practice.

Hogan JJ, Mocanu M, Berns JS.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):354-62. doi: 10.2215/CJN.05750515. Epub 2015 Sep 2. Review.

26.

False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.

Lin J, Fernandez H, Shashaty MG, Negoianu D, Testani JM, Berns JS, Parikh CR, Wilson FP.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1723-31. doi: 10.2215/CJN.02430315. Epub 2015 Sep 3.

27.

Improving Care of Patients With CKD: The 2015 National Kidney Foundation Presidential Address.

Berns JS.

Am J Kidney Dis. 2015 Oct;66(4):547-51. doi: 10.1053/j.ajkd.2015.07.012. Epub 2015 Aug 1. No abstract available.

PMID:
26243584
28.

Quality training, quality board examinations, quality nephrologists.

Berns JS, Ikizler TA.

Am J Kidney Dis. 2015 Jul;66(1):7-8. doi: 10.1053/j.ajkd.2015.05.002. No abstract available.

PMID:
26111903
29.

Kidney diseases associated with haematological cancers.

Ganguli A, Sawinski D, Berns JS.

Nat Rev Nephrol. 2015 Aug;11(8):478-90. doi: 10.1038/nrneph.2015.81. Epub 2015 Jun 2. Review.

PMID:
26035773
30.

Drugs, Dialysis, Decisions, and Data: A Walk through the Minefield of Nephropharmacology.

Perry Wilson F, Nolin TD, Berns JS.

Semin Dial. 2015 Jul-Aug;28(4):323-4. doi: 10.1111/sdi.12390. Epub 2015 May 1. No abstract available.

PMID:
25929704
31.

Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease.

Bansal AD, Hill CE, Berns JS.

Semin Dial. 2015 Jul-Aug;28(4):404-12. doi: 10.1111/sdi.12385. Epub 2015 May 1. Review.

PMID:
25929593
32.

Clinical Decision Making in a Patient with Stage 5 CKD--Is eGFR Good Enough?

Berns JS.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2065-72. doi: 10.2215/CJN.00340115. Epub 2015 Apr 16.

33.

Erythropoietin and resistant hypertension in CKD.

Boyle SM, Berns JS.

Semin Nephrol. 2014;34(5):540-9. doi: 10.1016/j.semnephrol.2014.08.008. Review.

PMID:
25416663
34.

Moving away from hemoglobin-based anemia performance measures in dialysis patients.

Berns JS.

Am J Kidney Dis. 2014 Oct;64(4):486-8. doi: 10.1053/j.ajkd.2014.06.022. No abstract available.

PMID:
25257323
35.

Routine screening for CKD should be done in asymptomatic adults... selectively.

Berns JS.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1988-92. doi: 10.2215/CJN.02250314. Epub 2014 Sep 18.

36.

25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report.

Kramer H, Berns JS, Choi MJ, Martin K, Rocco MV.

Am J Kidney Dis. 2014 Oct;64(4):499-509. doi: 10.1053/j.ajkd.2014.05.018. Epub 2014 Jul 28.

PMID:
25082101
37.

Measuring vitamin, mineral, and trace element levels in dialysis patients.

Shaban H, Ubaid-Ullah M, Berns JS.

Semin Dial. 2014 Nov-Dec;27(6):582-6. doi: 10.1111/sdi.12260. Epub 2014 Jul 1. No abstract available.

PMID:
24980893
38.

Training the next generation's nephrology workforce.

Berns JS, Ellison DH, Linas SL, Rosner MH.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1639-44. doi: 10.2215/CJN.00560114. Epub 2014 Jun 26.

39.

Are we paying our housestaff fairly?

Morris JB, Burke SV, Berns JS.

Ann Surg. 2014 Jul;260(1):1-2. doi: 10.1097/SLA.0000000000000703. Review. No abstract available.

PMID:
24743629
40.

Should nephrology training programs continue to train fellows in the placement of temporary hemodialysis catheters?

Negoianu D, Berns JS.

Semin Dial. 2014 May-Jun;27(3):245-7. doi: 10.1111/sdi.12207. Epub 2014 Mar 25. Review. No abstract available.

PMID:
24666034
41.

Dialysis versus nondialysis in patients with AKI: a propensity-matched cohort study.

Wilson FP, Yang W, Machado CA, Mariani LH, Borovskiy Y, Berns JS, Feldman HI.

Clin J Am Soc Nephrol. 2014 Apr;9(4):673-81. doi: 10.2215/CJN.07630713. Epub 2014 Mar 20.

42.

Chronic kidney disease in patients with renal cell carcinoma.

Chang A, Finelli A, Berns JS, Rosner M.

Adv Chronic Kidney Dis. 2014 Jan;21(1):91-5. doi: 10.1053/j.ackd.2013.09.003. Review.

PMID:
24359991
43.

Tumor lysis syndrome: new challenges and recent advances.

Wilson FP, Berns JS.

Adv Chronic Kidney Dis. 2014 Jan;21(1):18-26. doi: 10.1053/j.ackd.2013.07.001. Review.

44.

Cancer and the kidney: the growth of onco-nephrology.

Perazella MA, Berns JS, Rosner MH.

Adv Chronic Kidney Dis. 2014 Jan;21(1):4-6. doi: 10.1053/j.ackd.2013.09.002. No abstract available.

PMID:
24359981
45.

The impact of documentation of severe acute kidney injury on mortality.

Wilson FP, Bansal AD, Jasti SK, Lin JJ, Shashaty MG, Berns JS, Feldman HI, Fuchs BD.

Clin Nephrol. 2013 Dec;80(6):417-25. doi: 10.5414/CN108072.

46.

Dabigatran and kidney disease: a bad combination.

Knauf F, Chaknos CM, Berns JS, Perazella MA.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1591-7. doi: 10.2215/CJN.01260213. Epub 2013 Jul 18. Review.

47.

Is eliminating the floor for the Hb range consistent with patient-centered care?

Berns JS.

Nephrol News Issues. 2013 Jun;27(7):Supp 15-6. No abstract available.

PMID:
23855145
48.

Handoff communication between hospital and outpatient dialysis units at patient discharge: a qualitative study.

Reilly JB, Marcotte LM, Berns JS, Shea JA.

Jt Comm J Qual Patient Saf. 2013 Feb;39(2):70-6.

PMID:
23427478
49.

Can frequent hemodialysis be too frequent?

Berns JS, Dember LM.

J Am Soc Nephrol. 2013 Feb;24(3):334-6. doi: 10.1681/ASN.2013010007. Epub 2013 Feb 14. No abstract available.

50.

Erythropoiesis-stimulating agents on trial: are higher dosages causing harm?

Chaknos CM, Berns JS.

Am J Kidney Dis. 2013 Jan;61(1):6-8. doi: 10.1053/j.ajkd.2012.10.004. No abstract available.

PMID:
23245737

Supplemental Content

Loading ...
Support Center